• Founded: 2014
  • Location: Cambridge, MA
  • Employee range: 50 - 200
  • Clinical stage: Clin3
  • Therapy area: Phenylketonuria (ODD)
  • Drug types: GEN, PED, RAR, RHU, GI, IMM
  • Lead product: SYNB1934
  • Product link:
  • Funding: $45M stock Sep 2021; $80M Ginkgo Jun 2019

job board

Short description:

Synthetically engineered, therapeutic microbes

Drug notes:

SYNB1353 Clin1 homocystinuria; SYNB8802 Clin1 enteric hyperoxaluria; SYNB2081 Clin0 gout; 2 undisclosed programs Clin0 IBD

Long description:

Contact us to add description:


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy